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Analogue of Rodent Serial Reaction Time Task
Valerie Voon, Michael A. Irvine, Katherine Derbyshire, Yulia Worbe, Iris Lange, Sanja Abbott,
Sharon Morein-Zamir, Robyn Dudley, Daniele Caprioli, Neil A. Harrison, Jonathan Wood,
Jeffrey W. Dalley, Edward T. Bullmore, Jon E. Grant, and Trevor W. RobbinsBackground: Premature responding is a form of motor impulsivity that preclinical evidence has shown to predict compulsive drug
seeking but has not yet been studied in humans. We developed a novel translation of the task, based on the rodent 5-choice serial
reaction time task, testing premature responding in disorders of drug and natural food rewards.
Methods: Abstinent alcohol- (n ¼ 30) and methamphetamine-dependent (n ¼ 23) subjects, recreational cannabis users (n ¼ 30), and
obese subjects with (n ¼ 30) and without (n ¼ 30) binge eating disorder (BED) were compared with matched healthy volunteers and
tested on the premature responding task.
Results: Compared with healthy volunteers, alcohol- and methamphetamine-dependent subjects and cannabis users showed greater
premature responding with no differences observed in obese subjects with or without BED. Current smokers exhibited greater
premature responding versus ex-smokers and nonsmokers. Alcohol-dependent subjects also had lower motivation for explicit monetary
incentives. A Motivation Index correlated negatively with alcohol use and binge eating severity.
Conclusions: Premature responding on a novel translation of a serial reaction time task was more evident in substance use disorders
but not in obese subjects with or without BED. Lower motivation for monetary incentives linked alcohol use and binge eating severity.
Our ﬁndings add to understanding the relationship between drug and natural food rewards.Key Words: Binge eating, impulsivity, motivation, obesity,
premature responding, substance use disorders
Impulsivity can be broadly divided into decisional and motoricsubtypes. Here we focus on a speciﬁc form of motor impulsivity,namely anticipatory or premature responding (1). In preclinical
studies, premature responding is studied with the 5-choice serial
reaction time task (5-CSRTT), a test for visual attention in which
rodents monitor and respond to unpredictable visual targets (1).
Premature responding is measured as anticipatory responding
before target onset. Other forms of motor impulsivity include motor
response inhibition or the inability to inhibit a prepotent motor
response. The other major subgroup of impulsivity, decisional
impulsivity, includes delay discounting—the tendency to select a
smaller immediate reward over a larger delayed reward—and
reﬂection impulsivity—the tendency to make rapid decisions with-
out adequate consideration of options. These various subtypes of
impulsivity are associated with broadly distinct but partially over-
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impulsivity [reviewed in Perry and Carroll (3)], which can occur
both as a consequence of and a predictor of substance use
disorders. In rodents, premature responding is elevated after
methamphetamine (5) and alcohol withdrawal (6) and is also
inﬂuenced by cannabinoid receptor CB1 receptor antagonists (7).
High levels of premorbid premature responding and impulsive
choice have also been shown to predict the transition to
compulsive cocaine use in rodents (8), substantiating a potential
role of premature responding as a predictor of future risk for
substance use disorders. Although premature responding has
been extensively studied in experimental animal models, prema-
ture responding with an analogous task has not yet been
translated to studies in humans.
We developed a novel translation of the 5-CSRTT to assess
premature responding in abstinent alcohol- and methamphet-
amine-dependent subjects and recreational cannabis users, com-
pared with age- and gender-matched healthy volunteers. To
compare drug versus natural rewards, we also assessed prema-
ture responding in obese subjects with and without binge eating
disorder (BED). We assessed premature responding as a primary
outcome and motivation for explicit reward as an exploratory
measure. We hypothesized that premature responding would be
elevated in abstinent alcohol- and stimulant-dependent subjects
and recreational cannabis subjects. We hypothesized that obese
subjects with BED would be elevated in premature responding,
similarly to those with substance addiction.
Methods and Materials
Recruitment
Abstinent subjects with alcohol dependence (EtOH) (n ¼ 30),
obese subjects (30 body mass index [BMI]) with BED (n ¼ 30),
obese control subjects without BED (n ¼ 30), and recreationalBIOL PSYCHIATRY 2014;75:148–155
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V. Voon et al. BIOL PSYCHIATRY 2014;75:148–155 149cannabis users (Cann) (n ¼ 30) were recruited via community and
university-based advertisements in Cambridge. Age- and gender-
matched healthy volunteers (HV) (1:1 HV matching were used for
EtOH, BED, and obese control subjects; 1:2 HV matching was used
for Cann) were recruited via community- and university-based
advertisements in Cambridge (HV: n ¼ 30, n ¼ 30, n ¼ 30, n ¼ 60,
respectively). A total of 110 HV were recruited in Cambridge.
Abstinent methamphetamine-dependent subjects (Meth) (n ¼ 23)
were also recruited from an inpatient rehabilitation center in Eden
Prairie, Minnesota. Twenty age-matched HV were recruited from
community advertisements in Minneapolis. Primary diagnoses
were conﬁrmed by a psychiatrist with the DSM IV-TR criteria for
substance dependence or Research Diagnostic Criteria for BED (9).
None of the Cann subjects fulﬁlled criteria for dependence.
Subjects 18 years old were included. The HV, EtOH, obese
BED, obese control subjects, and Cann subjects were excluded
if they had a current major depression or other major psychiatric
disorder including substance addiction (except nicotine), major
medical illness, or were taking psychotropic medications. The
EtOH subjects were tested 2 weeks–1 year after abstinence and
1 week after discontinuation of long-acting benzodiazepines
used during detoxiﬁcation. Subjects were excluded if they had
positive urine drug screens or alcohol breathalyzer test on testing
day. Positive cannabis urine drug screen was allowed for Cann
subjects, because metabolites can be detected 3 weeks after
last use.
The Meth subjects were tested 1 week–1 year after abstinence
and excluded if they had current major depressive episode of
moderate severity (Beck Depression Inventory [BDI] 20), other
major psychiatric history, or medical illness. Because human
immunodeﬁciency virus (HIV) frequency is high, a subanalysis
was conducted. Other forms of substance addiction were allowed,
assuming the primary drug for rehabilitation admission was
methamphetamine (self-identiﬁed, highest frequency use, and
escalating use before admission). Regular drug screens wereFigure 1. Premature responding task. (A) Task. Subjects press and hold down
After a green circle (Target) appears in one of the boxes, the subject releases t
main outcome measure, premature responding, is measured as release of
individualized on the basis of the mean fastest reaction time (RT) and SD obtconducted at the rehabilitation center. All psychiatric diagnoses
were conﬁrmed by a psychiatrist with DSM IV-TR criteria.
For HV, EtOH, obese BED, obese control subjects, and Cann
subjects, two separate speciﬁcally designed questionnaires were
used to assess drug use (e.g., type, duration of use, amount/week,
last use). Psychiatric disorders were screened with the Mini
International Neuropsychiatric Interview (10). Subjects completed
the UPPS-P Impulsive Behaviour Scale (11) and BDI (12). The EtOH
and obese subjects completed the Alcohol Use Disorders Identi-
ﬁcation Test (13), and obese subjects completed the Binge Eating
Scale (BES) (14). The National Adult Reading Test (15) was used to
obtain an index of premorbid IQ.
Subjects were paid for their study participation time and told
they could receive an additional amount (£5) for their perform-
ance. Subjects in Minnesota were given the equivalent amount in
a department store gift card. The study was approved by the
University of Cambridge Research Ethics Committee and the
University of Minnesota Institutional Review Board.
Task
Subjects were seated in front of a touch screen (a Paceblade
Tablet personal computer; Paceblade Technology, Amersfoort, the
Netherlands). When four boxes appeared on the screen, the subject
pressed and held down the space bar on the keyboard with their
dominant index ﬁnger (Figure 1). The space bar press indicated the
“cue onset” time. After a speciﬁed period (cue-target interval), a
green circle target appeared brieﬂy and randomly in one of the four
boxes. Subjects released the space bar and touched the box on the
screen in which the target had appeared. The primary outcome
measure was premature release of the space bar before target onset.
The block order was as follows: Baseline block 1; Test block 1;
Baseline block 2; Test blocks 2–4. Baseline blocks without monetary
feedback were used to individualize monetary feedback amounts
for subsequent blocks on the basis of the mean fastest reaction
time (RT) and SD of the individual (Figure 1). The four Test blocksthe space bar when they see four empty boxes (Cue) on the touch screen.
he space bar and touches the box in which the target had appeared. The
the space bar before target onset. (B) Feedback for the Test blocks is
ained in the Baseline block.
www.sobp.org/journal
150 BIOL PSYCHIATRY 2014;75:148–155 V. Voon et al.with monetary feedback were optimized to increase premature
responding and varied by duration and variability of the cue-
target interval and the presence of distractors. See Supplement 1
for further task details. It was programmed in Visual Basic with
Visual Studio 2005 and Microsoft .NET Framework 2.0 (Microsoft,
Redmond, Washington) with the US currency equivalent for
feedback for subjects tested in Minnesota. Total task duration
was 20 min.
Motivation to reward feedback was calculated as Motivation
Index ¼ (Mean RT Baseline 1  Mean RT Baseline 2)/(Mean RT
Baseline 1  Mean RT Baseline 2). Test block 1 (with monetary
feedback) occurred between Baseline blocks (without feedback)
and had otherwise similar characteristics. Thus, Baseline 2 follows
instrumental learning with monetary feedback consistent with
testing in extinction without feedback. Other outcome measures
included accuracy (correct responses/[correct responses  incor-
rect responses]), correct trial RT (in Test block 1), late responses
(late responses/[correct fast responses  late responses]), which
correspond to errors of omission in the rodent paradigm, and
total won. Incorrect responses are errors of commission (wrong
box touched after target onset) (1) and are equivalent to the
accuracy measure: incorrect response ¼ 1  accuracy. Outlier RTs
(RT 3 SD from mean) were removed from analysis.
The HV were tested on the stop signal task (16), a test of motor
response inhibition and action cancellation, and a delay discount-
ing task (17), which assesses the preference for a smaller
immediate reward over a larger delayed reward. Primary outcome
measures included the slope of the discounting curve (K-value),
the go reaction time, and stop signal reaction time.
Statistical Analysis
Variables that were not normally distributed (Shapiro-Wilk
statistic p  .05) were transformed with square root trans-
formation. Outliers (3 SD above group mean) were removed.
The EtOH, Cann, Obese BED, and Obese control subjects and
Meth subjects were compared with their own matched HV with
independent t tests. To control for differences in BDI or IQ,
univariate analysis was conducted with BDI or IQ covariates.
Relationships between premature responding and Motivation
Index, disease severity measures, and task characteristics were
tested with Pearson’s correlation coefﬁcient r. Current smokers,Table 1. Subject Characteristics and Behavioral Measures
EtOH HV-EtOH
(n ¼ 30) (n ¼ 30) t
Age 41.40 (11.57) 42.47 (12.35) .35
Men (n) 18 18
IQ 114.32 (6.76) 116.13 (5.88) 1.11
BDI 12.89 (9.29) 5.62 (6.47) 3.52
UPPS-P 154.25 (20.14) 120.69 (26.29) 5.55
AUDIT 19.59 (14.10) 5.15 (3.81) 5.42
Premature Response 10.17 (8.79) 6.02 (4.36) 2.32
Accuracy .93 (.05) .92 (.06) .70
Late Response .06 (.05) .08 (.07) 1.27
Total Win 1087.53 (419.93) 1089.00 (400.10) .01
RT Baseline 1 394.96 (97.69) 369.48 (112.48) .94
RT Reward 339.38 (50.76) 316.39 (48.35) 1.80
RT Baseline 2 336.28 (91.83) 268.75 (63.89) 3.31
Motivation Index .08 (.10) .16 (.12) 2.81
Reported in mean (SD). AUDIT, Alcohol Use Disorders Identiﬁcation Test; BD
Scale; BMI, body mass index; Cann, recreational cannabis users; EtOH, abstine
UPPS-P, UPPS Impulsive Behaviour Scale.
www.sobp.org/journalex-smokers, and nonsmokers were compared with analysis of
variance. In Meth subjects, HIV and HIV− and high nicotine
(1 pack/day) and low or no nicotine were compared with
independent t tests. Statistical tests were two-tailed, and signiﬁ-
cance was assigned at p  .05.
Results
Abstinent Alcohol-Dependent Subjects
Thirty EtOH subjects (reported in mean [SD]: weeks abstinent
15.60 [16.89]; years heavy use: 12.78 [8.27]; units/day: 28.36
[14.58]; Total units [units/day  years heavy use  365  percent
drinking days]: 128,573 [124,490]) were compared with 30 HV. The
EtOH subjects had higher UPPS-P, Alcohol Use Disorders Identi-
ﬁcation Test, and BDI scores (Table 1). The EtOH subjects were
taking the following medications: acamprosate (n ¼ 2); and
disulﬁram (n ¼ 1).
Compared with HV, EtOH subjects made more premature
responses (Figure 2, Table 1), including when covaried for BDI
(F ¼ 8.99, p ¼ .004). The EtOH subjects also made more
premature responses compared with HV (t ¼ 2.36, p ¼ .023)
when subanalyzed to exclude the three subjects taking medi-
cations with possible psychotropic effects. In the secondary
analysis, EtOH subjects had decreased motivation to reward
feedback (Motivation Index) (Figure 2, Table 1). There were no
differences in premature responding between current (n ¼ 12,
10.71 [8.20]), past (n ¼ 4, 9.5 [7.14]), and nonsmokers (n ¼ 11,
10.72 [9.82]) (F ¼ .06, p ¼ .941).
In EtOH subjects, there was no correlation between premature
responding and severity (total units), duration abstinence, or
Motivation Index (reported as Pearson correlation coefﬁcient:
r ¼ .09–.18, p  .05). However, there was a negative correlation
between Motivation Index with total units (r ¼ .43, p ¼ .019).
Recreational Cannabis Users
Thirty Cann subjects (reported in mean [SD]: number of joints/
week 6.64 [5.21]; number of years 5.12 [4.21]; 5 did not report the
amount) were compared with 60 HV. The Cann subjects had
higher UPPS-P scores compared with HV. The Cann subjects made
more premature responses compared with HV (Figure 2, Table 1),
including when subanalyzed without those with positive cannabisCann HV-Cann
p (n ¼ 30) (n ¼ 60) t p
.730 25.33 (7.53) 26.42 (7.74) .64 .527
18 46
.273 116.76 (5.89) 117.18 (5.70) .32 .745
 .001 9.81 (8.99) 6.18 (6.73) 2.15 .034
 .001 141.38 (19.52) 129.81 (22.03) 2.44 .017
 .001
.024 10.39 (8.34) 7.01 (4.53) 2.50 .014
.486 .89 (.09) .91 (.07) 1.16 .250
.208 .08 (.07) .07 (.08) .58 .562
.989 950.39 (413.33) 1044.06 (463.52) .94 .352
.353 345.93 (113.77) 342.05 (97.97) .17 .867
.077 319.82 (27.34) 304.15 (32.72) .23 .831
.002 258.99 (112.74) 256.90 (80.75) .37 .714
.007 .14 (.12) .15 (.14) .40 .679
I, Beck Depression Inventory; BED, binge eating disorder; BES, Binge Eating
nt alcohol-dependent subjects; HV, healthy volunteers; RT, reaction time;
Figure 2. Premature responding and motivation index. (A) Premature
responses in abstinent alcohol- (EtOH) (n ¼ 30) and methamphetamine-
dependent (Meth) (n ¼ 23) subjects, recreational cannabis users (Cann)
(n ¼ 30), and obese subjects with binge eating disorder (BED) (n ¼ 30)
(Index group ¼ red) versus healthy volunteers (HV) (black) and obese
control subjects without BED (white) (n ¼ 30). (B) Premature responses in
current and past HV smokers and nonsmokers. (C) Motivation Index in
EtOH (n ¼ 30) versus HV. Error bars represent SEM. *p  .05; **p  .005.
V. Voon et al. BIOL PSYCHIATRY 2014;75:148–155 151urine drug screens (n ¼ 19, premature responding 11.41 [8.13],
t ¼ 2.99, p ¼ .004).
Obese Subjects with and without BED
Thirty obese BED and 30 obese control subjects were
compared with their own age- and gender-matched HV. The
groups differed by BMI, BES, and BDI scores (Table 2). There were
no differences in premature responses or Motivation Index
between obese BED and HV and obese control subjects and HV
(Figure 2, Table 2).
In obese subjects with and without BED, there was no
correlation between premature responding and BES, BMI, or
Motivation Index (r ¼ .19–.002, p  .05). There was a negative
correlation between Motivation Index and BES (r ¼ .37, p ¼ .012)
but not BMI (r ¼ .20, p ¼ .128).
Abstinent Methamphetamine-Dependent Subjects
Twenty-three Meth subjects (reported in mean [SD]: days
abstinent: 79.16 [140.28]; years ever used: 10.16 [6.31]; years of
heavy use: 2.60 [2.51]; Penn Craving Scale: 15.17 [9.17]) were
compared with 20 HV from Minnesota (Table 2). Data from one
Meth subject were excluded, due to a moderately severe current
major depressive episode. Six Meth subjects had a concurrent
alcohol use disorder, and 21 used nicotine daily. Meth subjects
had the following comorbid psychiatric diagnoses: lifetime major
depression (n ¼ 4); panic disorder (n ¼ 1); posttraumatic stress
disorder (n ¼ 1); obsessive-compulsive disorder (n ¼ 1); anorexia
nervosa/bulimia (n ¼ 1); compulsive sexual behaviors (n ¼ 2); andattention-deﬁcit/hyperactivity disorder (n ¼ 4). Meth subjects
were taking the following medications: antidepressant (n ¼ 9);
mood stabilizer (n ¼ 3) (used also for pain); neuroleptic (n ¼ 2);
and medication status unknown (n ¼ 2).
The Meth subjects had a lower IQ and higher BDI and UPPS-P
scores compared with HV (Table 2). The Meth subjects had higher
premature responding compared with HV (Figure 2, Table 2)
including when co-varied for BDI and IQ (F  4, p  .05). There
were no differences in premature responding (reported in mean
[SD]: HIV 14.09 [11.32], HIV− 14.00 [6.29], t ¼ .02, p ¼ .981) or
Motivation Index (HIV .12 [.14], HIV− .12 [.10], t ¼ .08, p ¼ .947)
in Meth subjects who were HIV− (n ¼ 11) versus HIV (n ¼ 11)
or who had a concurrent alcohol use disorder (n ¼ 6) versus those
that did not (n ¼ 16) (t ¼ 1.75 –.21, p  .05). There were no
differences in premature responding between heavy (1 ppd,
n ¼ 11, 14.73 [7.72]) and light/nonsmokers (n ¼ 9, 11.67 [5.36])
(t ¼ 1.00, p ¼ .332).
In Meth subjects, premature responding or Motivation Index
did not correlate with duration of use, Penn Craving Scale score
or duration of abstinence (r ¼ .33–.08, p ¼ .141–.634).
HV and Nicotine Use
Nicotine use was compared in a subgroup of HV. Current
smokers (n ¼ 19, 9 men [47%], age in years 30.00 [10.63], years
smoked 12.27 [9.39]) had greater premature responding com-
pared with past smokers (n ¼ 12, 3 men [25%], age in years 39.75
[16.08], years smoked 6.31 [5.00]) and nonsmokers (n ¼ 60, 28
men [47%], age in years 31.25 [11.89]) (age: F ¼ 2.76, p ¼ .07;
gender: χ2 ¼ 2.02, p ¼ .357; premature responding: F ¼ 4.51,
p ¼ .013) (Figure 2). Premature responding remained signiﬁcantly
different when covaried for age and gender (F ¼ 4.22, p ¼ .022).
Relationship with Other Measures
In HV, premature responding did not correlate with the UPPS-P
(reported as Pearson correlation coefﬁcient r: n ¼ 110, r ¼ .13,
p ¼ .372), Barratt Impulsiveness Scale (n ¼ 60, r ¼ .14, p ¼ .391),
Motivation Index (n ¼ 110, r ¼ .09, p ¼ .382), Go Reaction Time
(mean 445.39 [SD 105.38]; n ¼ 55, r ¼ .15, p ¼ .327), stop signal
reaction time (mean 175.71 [SD 45.11]; n ¼ 55, r ¼ .07, p ¼ .62), or
Delay Discounting Task (mean .02 [SD .02]; n ¼ 80, r ¼ .11, p ¼
.397). In HV, premature responding was negatively correlated with
age (n ¼ 110, r ¼ .25, p ¼ .004) but not IQ (n ¼ 110, r ¼ .10,
p ¼ .50). When all groups were considered both in the HV and for
each subject group, premature responding also did not correlate
with Motivation Index (r ¼ .13–.16, p  .05) or with IQ, BDI, or
task measures including accuracy, RT, late responses, or amount
won (p  .05). There were no gender differences in HV or each
subject group in premature responding or Motivation Index
(p  .05).Discussion
We developed a novel task for premature responding adapted
from the preclinical 5-CSRTT and demonstrate its translational
utility in clinical subjects. In keeping with our hypotheses, the
main ﬁndings indicate that subjects abstinent from alcohol and
methamphetamine dependence exhibited signiﬁcantly more
premature responding compared with HV. Recreational cannabis
users were also more impulsive on this novel task than HV,
a behavioral impairment shared by current smokers but not ex-
smokers or nonsmokers. However, obese subjects with and
without binge eating did not show elevated levels of prematurewww.sobp.org/journal
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www.sobp.org/journalresponding compared with HV. Obesity, with food as a natural
reward, and substance addictions, with drug as an exogenous
reward, have overlaps, but its relationship is not without con-
troversy (18). The comparison of obesity and binge eating with
substance addiction with the same measure allows a direct
assessment of the relationship with substance addiction. That
subjects with BED were not elevated in premature responding did
not support our hypothesis. Here we highlight differences
between obesity and binge eating with substance addictions,
on the basis of the premature responding measure, a form of
motor impulsivity. Our ﬁndings dovetail with recent preclinical
studies showing premature responding is both a consequence of
(i.e., a state effect) (5) and a predictor of and risk factor (i.e., a trait
effect) for the transition to compulsive cocaine and nicotine use
(19,20). Because our study assesses subjects cross-sectionally after
substance exposure, we are unable to distinguish between state
and trait effects or to assess whether subjects are self-medicating
a pre-existing condition. Future studies in unaffected family
members are required to address these differences.
Stimulant Dependence
In the stimulant dependence preclinical literature, rodents
with high premature responding have lower ventral striatal D2/D3
receptors (21) and are at greater risk for the development of
compulsive cocaine seeking. Thus, rodents with high levels of
premorbid premature responding have greater motivation to take
cocaine and inability to inhibit drug seeking, despite aversive
consequences (8). In humans, low striatal D2/D3 receptor avail-
ability is associated with impulsivity in both methamphetamine-
dependent subjects and HV, arguing for premorbid trait effects
(22). Equally, in rodents, greater premature responding for up to
2 weeks after chronic methamphetamine exposure suggests
premature responding can also be a consequence of metham-
phetamine abuse (5).
Methamphetamine blocks reuptake and enhances release of
norepinephrine and dopamine and, to a much lesser extent,
serotonin (23). In primates, methamphetamine is associated with
striatal dopaminergic neurodegeneration (24,25) with substantial
but incomplete recovery after 18 months (26). In humans, persis-
tently reduced dopamine transporter (27) and D2/D3 receptor
density (28) is partially reversible after prolonged abstinence (27).
Several lines of preclinical evidence suggest that dopamine,
serotonin, and norepinephrine modulate impulsive action. Rodents
with high premature responding have lower ventral striatal D2/D3
receptors (21). Acute amphetamine increases premature responding
in rodents, an effect attenuated by 6-hydroxydopamine lesions of
the nucleus accumbens and by D1/D2 receptor antagonists (29).
Central serotonin depletion or 5-HT2C receptor antagonism is also
associated with greater premature responding in rodents (30).
Atomoxetine, a selective norepinephrine-reuptake inhibitor also
dose-dependently decreases premature responding (31). Studies of
unaffected family members are indicated to differentiate possible
neurochemical state and trait effects.
Alcohol Dependence
Abstinent subjects with alcohol dependence also had greater
premature responding. However, in contrast to the preclinical
literature on stimulants, the role of premature responding as a
predictor for alcohol dependence is less well-established. Prema-
ture responding was positively associated with greater withdrawal
severity from chronic alcohol in a study of 15 different inbred
strains of mice (32). Acute alcohol exposure (33) and early but not
late abstinence after chronic alcohol exposure is associated with
V. Voon et al. BIOL PSYCHIATRY 2014;75:148–155 153increased premature responding in rodents (6). Thus, premature
responding is a state effect of alcohol, but its status as a trait effect
is less clear.
Binge Eating and Obesity
The relationship between premature responding and binge
eating is also not well-established. In rodents, high premorbid
premature responding is associated with greater escalation of
sucrose-seeking behavior and reinstatement after extinction (34).
By contrast, premature responding in 15 different strains of mice
is not associated with sucrose acquisition or preference (32). Our
ﬁnding that obese subjects were not elevated in premature
responding is consistent with these preclinical ﬁndings.
Cannabis Use
In rodents, the cannabinoid CB1 receptor antagonist, SLV330,
decreases premature responding (7). Recreational cannabis users
have elevated impulsivity as measured with questionnaires and
behavioral tasks including impulsive choice, motor response
inhibition, and reﬂection impulsivity (35,36). In the present study,
recreational cannabis users made more premature responses
despite exclusion of those screening positive for cannabis
metabolites, suggesting that our ﬁndings were not related to
acute cannabis effects.
Nicotine Use
Premature responding is associated with nicotine use as both
a state and trait effect. In rodents, nicotine increases premature
responding (37), and high premorbid premature responding
predicts greater motivation to initiate and maintain nicotine use
(20). That current smokers have greater premature responding,
compared with ex-smokers and nonsmokers, suggests a clear
state effect of nicotine that might be associated with greater
likelihood of ongoing use but does not support a trait effect.
Relationship to Other Tasks and Measures
We have stringently and operationally deﬁned premature
responding with a translation of the preclinical 5-CSRTT [itself
based on a human paradigm; see Robbins (1)]. The task
incorporates measures to optimize premature responding, includ-
ing decreasing target time, variable cue-target intervals after
repeated responding at ﬁxed short intervals, and introduction of a
distractor (1). The premature responding measure is also differ-
entiated from other measures of inattention, accuracy, and
sensitivity to reward feedback. Other studies have assessed
impulsive action with continuous performance tasks in which
subjects respond quickly to targets and must withhold respond-
ing to catch trials (38,39). These tasks capture a form of motor
impulsivity measured as commission errors consistent with motor
response inhibition or action restraint assessed as in the Go/NoGo
paradigm. Premature responding has also been assessed in the
context of high conﬂict in the Simon task deﬁned as rapid
response errors (40) and rapid responding to high conﬂict stimuli
(41). This form of premature responding might be more speciﬁc
to situations of high conﬂict. Anticipatory responding has also
been assessed in the context of risky time-sensitive rewards (42)
and might also be sensitive to reward or loss value. Thus, other
tasks measuring impulsive action might measure other forms of
motor control or be speciﬁc to the context of conﬂict, risk, or
reward sensitivity.
In this study, premature responding correlated negatively with
increasing age, consistent with the trajectory of impulsivity with
age (43). The measure did not correlate with impulsivityquestionnaires, which is a common observation in the compar-
ison of questionnaire and laboratory-based measures (44). We
show that this novel task is independent of other subtypes of
impulsivity, such as stopping and delay discounting. Inhibitory
mechanisms might be implicated but might differ, depending on
whether it is anticipatory or postinitiation. In the rodent 5-CSRTT,
differences between premature responding and false errors
(analogous to Go/NoGo or Continuous Performance Task com-
mission errors) have been highlighted (45). The issue of proactive
stopping (46) or preparing to suppress a response tendency
rather than reactive stopping after signal onset might be relevant.
In the rodent literature, premature responding can correlate with
delay discounting (47), although the neural substrates might not
be identical (4). That we did not observe a relationship might
reﬂect task differences: in rodents, delay discounting is tested
with short delays in seconds with rewarding feedback, whereas
the questionnaire uses delays in days–months without feedback.
A discounting task in real time with feedback is indicated (48).
Premature responding did not correlate with IQ, depression
scores, accuracy, RT, late responses, amount of money won, or
motivation for monetary feedback. The accuracy measure
accounts for variations in accuracy due to nonspeciﬁc inﬂuences
such as attentional capacity, motivation, or motor behavior,
because correct and incorrect responses require the same motor
effort (1).
Motivation
We also show that motivation for monetary incentive as
measured by the Motivation Index is decreased in abstinent
alcohol-dependent subjects and is negatively correlated with
severity of alcohol dependence and binge eating. This measure
of motivation, which assesses RT in extinction after instrumental
conditioning with monetary feedback, is unrelated to premature
responding. Because monetary reward in these disorders is a
conditioned reinforcer, our ﬁndings suggest possible similarities
between substance use disorders and a subtype of obesity
characterized by the pattern of food intake or binge eating. This
ﬁnding dovetails with the observation of decreased ventral
striatal activity to anticipation of monetary reward with an
increase in activity to alcohol cues in alcohol-dependent subjects
(49). These data are thus consistent with rodent studies in which
sugar bingeing demonstrates addictive-like properties including
enhanced responding for sugar after abstinence, amphetamine
cross-sensitization, and nucleus accumbens dopamine release
(50). In humans, food presentation to BED subjects is associated
with greater striatal dopamine release (51). Our data add to the
growing literature addressing the relationship between obesity
and substance use disorders.
Study Limitations
There were several limitations. In the obese subjects, testing
under food restriction might inﬂuence these ﬁndings. Using the
primary reinforcer (e.g., food) might also affect these ﬁndings,
although monetary outcome is a conditioned reinforcer in all the
diagnostic groups tested. Nicotine use was not deﬁned a priori as
a group, and the sample size of ex-smokers was low although
well-matched for age and gender. Further studies focusing on
nicotine use are indicated, although these preliminary ﬁndings
are strongly suggestive of a possible effect. Relative to HV,
methamphetamine-dependent subjects were not matched for
gender and had a lower IQ, and methamphetamine and alcohol-
dependent subjects had higher depression scores. However, we
show that IQ, gender, and depression scores are unrelated towww.sobp.org/journal
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portant. Other forms of impulsivity have also been shown to be
independent of IQ (52). Lower premorbid IQ has been reported to
be associated with stimulant dependence (53). Cognitive changes
might also change with more prolonged abstinence.
Conclusions
With a novel translational task, we show that premature
responding is elevated in subjects with substance dependence
and recreational cannabis use but not in obese subjects with or
without binge eating. Alcohol use and binge eating severity were
linked by a blunted motivation for monetary rewards. Our
ﬁndings help to elucidate the complex relationship between
drug and natural food reward and suggest binge eating might
represent a speciﬁc subtype in the mechanisms underlying
obesity. Studies in high-risk populations are warranted to assess
the role of premature responding as a biomarker for the develop-
ment of substance addiction.
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